PLT Health Solutions, Inc. announced BioTRUST Nutrition® LLC, a leading eCommerce-based nutrition brand with a portfolio of high-quality, science-backed products focused on healthy aging and improving healthspan, has introduced a new product...
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in its named patient program in Italy for TLX250-CDx (89Zr-DFO-girentuximab, Zircaix™. TLX250-CDx is the Company's investigational...
TransPerfect Life Sciences, a leading global provider of solutions for product development and launch for the biopharmaceutical industry, today announced that Gedeon Richter selected Trial Interactive's award-winning eTMF platform and TI...
Aptamer Sciences Inc. (KOSDAQ, 291650) announced the filing of an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201. AST-201, the company's pioneering candidate in its pipeline, is an ApDCTM (Aptamer-Drug...
RadiusXR, the trailblazer in Digital Health, announces the publication of its groundbreaking NOVA Clinical Trial in Translational Vision Science and Technology (TVST), a prestigious journal by the Association for Research in Vision and...
Entourage Phytolab, under the leadership of Brazilian entrepreneur Caio Abreu, announces its launch on One Lavi. Known for its commitment to quality and innovation, Entourage Phytolab is set to bring its Entourage Liquid Fusionner™ – Night Use...
Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, announced three poster presentations at the 2024...
Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity, announced the creation of the Ginkgo Technology Network. A groundbreaking ecosystem of cutting edge technology partners, each committed to collaborating...
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has obtained prequalification (PQ) certification from the World Health Organization (WHO). For...
Decades of research reveal that maintaining high NAD+ levels significantly supports the body's ability to age well. Neurohacker Collective's new supplement, Qualia NAD+, demonstrated an 85% increase in NAD+ levels in a preliminary clinical...
HemoSonics, LLC, a medical device company focused on acute bleeding management, announced that its Quantra Hemostasis System with QPlus® and QStat® Cartridges has been named a finalist in the 2024 Edison™ Awards. The company was honored in the...
Improved Pharma is pleased to announce expanded capabilities in collaboration with Chemical Microscopy for evaluating the thermal properties of micro-quantities of materials. The newly-added Mettler-Toledo HS84/HS1 DSC controller micro-DSC system...
Following the successful filing of Intellectual Property (IP) for their applied platform technology targeting the endocannabinoid system (ECS), Tetra Pharm Technologies, is moving forward with its compound for appetite suppression, TPT0701....
Rehabtronics, a leading innovator in neurostimulation technologies, is pleased to announce that it has been selected by the Praxis Spinal Cord Institute to conduct a usability and validation study for its groundbreaking pressure injury early...
Evogene Ltd. a leading computational biology company targeting to revolutionize life-science product development across multiple market segments, and Verb Biotics LLC. A microbiome health ingredient company whose mission is to improve human...
Viscient Biosciences ("Viscient") announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical research institute, and Salk Institute, have published the first demonstration of a...
CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), today announced the evolution of its loyalty program to include two membership tiers: ExtraCare® and ExtraCare Plus™. ExtraCare: The popular, no-fee loyalty program through which...
Octapharma USA has announced Balfaxar® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex®) is now available. The new non-activated four factor prothrombin complex concentrate (4F-PCC), approved by the U.S....
Editorial Guidelines At Pharmaceutical-Era.com, we strive to maintain the highest standards of quality and integrity in our editorial content. Our guidelines are designed to ensure that all articles, press releases, and other submissions are...
Terms Of Use — Terms & Conditions Welcome to Pharmaceutical-Era (referred to as "Pharmaceutical-Era," "we," "us," or "our"). By accessing or using our website (www.pharmaceutical-era.com), you agree to comply with and be bound by the following...
